Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

R2 Diagnostics, Inc. — Predicate Candidate Screening

10 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

256 daysmedian FDA review time
714 days90th percentile
10clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K102908NOFACT IXR2 Diagnostics, Inc.2011-12-194440
K102851NOFACT VIIIR2 Diagnostics, Inc.2011-12-194460
K090105LUPOTEK KCTR2 Diagnostics, Inc.2010-12-307140
K083878LUPOTEK CORRECTIN VL, LUPOTEK DETECTIN VL, PLASMACON LAR2 Diagnostics, Inc.2010-06-255430
K082631THROMBO TEK PSE, MODEL 90-480R2 Diagnostics, Inc.2008-12-17980
K062306PLASMACON N, PLASMACON L-1, PLASMACON L-2R2 Diagnostics, Inc.2007-03-162200
K050817T-TEKR2 Diagnostics, Inc.2005-12-122560
K042919FIBROTEK FIBR2 Diagnostics, Inc.2004-11-29380
K040296PHOSPHOPLASTIN RLR2 Diagnostics, Inc.2004-05-241050
K033471PHOSPHOLIN ES AND CALCIUM CHLORIDER2 Diagnostics, Inc.2004-02-04930

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda